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Tumor-promoting function of apoptotic
caspases by an amplification loop
involving ROS, macrophages and JNK in
Drosophila
Ernesto Pe´rez†‡, Jillian L Lindblad†, Andreas Bergmann*
Department of Molecular, Cell and Cancer Biology, University of Massachusetts
Medical School, Worcester, United States
Abstract Apoptosis and its molecular mediators, the caspases, have long been regarded as
tumor suppressors and one hallmark of cancer is ‘Evading Apoptosis’. However, recent work has
suggested that apoptotic caspases can also promote proliferation and tumor growth under certain
conditions. How caspases promote proliferation and how cells are protected from the potentially
harmful action of apoptotic caspases is largely unknown. Here, we show that although caspases are
activated in a well-studied neoplastic tumor model in Drosophila, oncogenic mutations of the
proto-oncogene Ras (RasV12) maintain tumorous cells in an ‘undead’-like condition and transform
caspases from tumor suppressors into tumor promotors. Instead of killing cells, caspases now
promote the generation of intra- and extracellular reactive oxygen species (ROS). One function of
the ROS is the recruitment and activation of macrophage-like immune cells which in turn signal
back to tumorous epithelial cells to activate oncogenic JNK signaling. JNK further promotes and
amplifies caspase activity, thereby constituting a feedback amplification loop. Interfering with the
amplification loop strongly reduces the neoplastic behavior of these cells and significantly improves
organismal survival. In conclusion, RasV12-modified caspases initiate a feedback amplification loop
involving tumorous epithelial cells and macrophage-like immune cells that is necessary for
uncontrolled tumor growth and invasive behavior.
DOI: https://doi.org/10.7554/eLife.26747.001
Introduction
Larval imaginal discs in Drosophila are single-cell layered sacs of epithelial cells that develop into the
adult appendages such as eyes and wings, and are frequently used as genetic models for growth
control and tumor development. Maintenance of apical-basal polarity of epithelial cells is critical for
suppression of neoplastic tumor development (Elsum et al., 2012; Bergstralh and St Johnston,
2012; Martin-Belmonte and Perez-Moreno, 2011). Mutations in genes encoding components of
the Scribble complex including scribble (scrib), lethal giant larvae (lgl) and discs large (dlg) disrupt
apical-basal polarity in epithelial cells which can trigger malignant neoplastic tumor growth
(Bergstralh and St Johnston, 2012; Elsum et al., 2012; Bilder et al., 2000; Gateff, 1978;
Bilder and Perrimon, 2000). Drosophila larvae entirely mutant for scrib fail to respond to stop sig-
nals of growth, fail to pupariate and continue to grow as larvae (Gateff, 1994; Wodarz, 2000). They
die as giant larvae with severely overgrown imaginal discs.
However, scrib mutant cells (clones) in otherwise wild-type imaginal discs are eliminated by cell
competition mediated by neighboring wild-type cells (Brumby and Richardson, 2003;
Mene´ndez et al., 2010; Igaki et al., 2009; Uhlirova et al., 2005; Ohsawa et al., 2011;
Leong et al., 2009; Chen et al., 2012; Vaughen and Igaki, 2016). Mechanistically, in response to
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cell competition, Eiger, the Tumor Necrosis Factor alpha (TNFa)-like ligand in Drosophila, triggers
Jun N-terminal kinase (JNK) activation and apoptosis in scrib mutant cells (Igaki et al., 2009;
Brumby and Richardson, 2003; Uhlirova et al., 2005; Cordero et al., 2010; Ohsawa et al., 2011;
Leong et al., 2009; Igaki et al., 2006; Chen et al., 2012). This tumor-suppressing function is depen-
dent on Eiger and JNK through induction of apoptosis. Inhibition of Eiger or JNK restores the
growth potential of scrib mutant cells which can then form large tumor masses in imaginal discs
(Brumby and Richardson, 2003; Igaki et al., 2009; Uhlirova et al., 2005; Chen et al., 2012).
However, if additional oncogenic mutations such as RasV12 are introduced into scrib mutant cells
(referred to a scrib /  RasV12), they can unleash their full malignant potential (Brumby and Richard-
son, 2003; Pagliarini and Xu, 2003). scrib /  RasV12 mosaic eye/antennal imaginal discs display all
neoplastic features observed in human tumors including unrestricted growth, failure to differentiate,
tissue invasion and organismal lethality (Pagliarini and Xu, 2003; Brumby and Richardson, 2003).
scrib /  RasV12 clones occupy a large portion of the mosaic disc and trigger multi-layered over-
growth of the entire disc compared to wild-type controls (Figure 1H,I). scrib /  RasV12 mutant cells
also invade other tissues, most notably the ventral nerve cord (VNC) in the brain (Figure 1H,I)
(Pagliarini and Xu, 2003). The scrib /  RasV12 condition in ey-FLP-induced eye imaginal disc mosaics
is 100% lethal. 95% of ey-FLP-induced scrib /  RasV12 mosaic animals die as larvae; the remaining
animals die during pupal stages.
Interestingly, RasV12 inhibits the apoptotic activity of JNK and converts the tumor-suppressor
function of Eiger and JNK in scrib /  cells into a tumor-promoting one in scrib /  RasV12 cells
(Enomoto et al., 2015; Cordero et al., 2010; Uhlirova et al., 2005; Igaki et al., 2006;
Uhlirova and Bohmann, 2006). Therefore, the aggressive tumor growth of scrib /  RasV12 mutant
clones becomes dependent on Eiger and JNK (Igaki et al., 2006; Uhlirova and Bohmann, 2006;
Brumby et al., 2011). Mechanistically, it is not understood how RasV12 promotes this oncogenic
switch of Eiger and JNK.
Caspases are Cys-proteases that mediate the mechanistic events of apoptotic cell death
(Shalini et al., 2015; Xu et al., 2009; Fuchs and Steller, 2011; Salvesen et al., 2016). They are syn-
thesized as zymogens and depending on the length of their prodomains can be classified into initia-
tor and effector caspases. Initiator caspases such as mammalian Caspase-9 or its Drosophila
ortholog Dronc are controlled by upstream signaling events and when activated initiate apoptosis
eLife digest Throughout the development and life of an animal, many of its cells die and are
removed to make space for new tissues. A group of proteins called caspases play a key role in this
cell death process. Chemotherapy and radiotherapy work as cancer treatments because they
damage dividing cancer cells to such an extent that caspases are turned on and kill those cells.
Unfortunately the tumor occasionally grows back after the treatment, partly because caspases also
help to produce signals that boost the growth of any surviving cancer cells.
Pe´rez, Lindblad and Bergmann have now used the fruit fly Drosophila to investigate how
caspases encourage tumor cells to grow and spread. The fruit flies all carried a mutation in a gene
called Ras, which is often mutated in human cancers. Using a combination of genetic and
biochemical experiments Pe´rez, Lindblad and Bergmann found that mutant Ras prevents cells with
active caspases from dying. Instead, the caspases redirect their activity and help cancer cells to
produce small chemicals called reactive oxygen species. These chemicals can play many different
roles in cancers, but in this setting they attract immune cells to the site of the tumor. The immune
cells in turn send other signals back to the cancer cells, which further activate the caspases. Overall,
this self-perpetuating signaling loop between the cancer cells and the surrounding immune cells
helps the tumors to grow.
Future work toward developing new cancer treatments will need to work on ways of enhancing
the cell-killing properties of caspases while inhibiting their ability to help tumors to grow. Further
experiments will also be needed to find out exactly how the mutant Ras gene protects tumor cells
from death.
DOI: https://doi.org/10.7554/eLife.26747.002
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Figure 1. Both intra- and extracellular ROS contribute to the strong neoplastic phenotype of scrib /  RasV12. Mosaic animals in this and subsequent
figures were obtained using the MARCM technique (Lee and Luo, 1999) with ey-FLP (Newsome et al., 2000) to induce mitotic recombination in eye
imaginal discs. GFP depicts MARCM clones. Posterior is to the right. (A–D’) Wild-type (wt, FRT +) (A), scribble (scrib / ) (B), RasV12–expressing (C) and
scrib /  RasV12 (D) eye/antennal mosaic imaginal discs from third instar larvae labeled with the ROS indicator Dihydroethidium (DHE). Scale bars: 50
mm. (E) Enlarged scrib /  RasV12 clones labeled for DHE. Arrowhead in (E’) marks a cell of high DHE labeling. (F) DHE quantification reveals that ROS
levels are significantly higher in scrib /  RasV12 mutant clones compared to wt (FRT +), scrib /  or RasV12-expressing clones. Plotted is the mean signal
intensity ±SD of DHE labelings in clones, analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p<0.0001; ns – not
significant. Multiple clones from five to ten discs of each genotype were analyzed. (G) Reduction of extra- and intracellular ROS levels in scrib /  RasV12
mutant clones significantly improves the pupariation rates of animals bearing scrib RasV12 mosaic eye imaginal discs. Expression of UAS-lacZ in scrib / 
RasV12 clones as control has no effect on the pupariation rate. Pupariation rates were determined as the ratio of late stage mutant pupae vs total pupae
and were analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are relative to scrib /  RasV12 results
(left column) and are indicated above the experimental columns. ****p<0.0001; ns – not significant. At least 100 pupae were counted per genotype.
Experiments were performed three times. (H–N) Cephalic complexes composed of eye/antennal discs, optic lobes (OL) and ventral nerve cord (VNC)
from day 11 old third instar larvae. The genotype is indicated on top of each panel. Expression of UAS-lacZ served as negative control (I). Depletion of
ROS strongly reduces clone size (green) and normalizes growth in (J–N). DAPI (blue) labels the outline of the tissue. Scale bars: 200 mm. (O–U) Adult
eyes of control (O) and scrib /  RasV12 mosaics expressing the indicated antioxidant transgenes (Q–U). The percentage number in the top right of each
panel indicates the adult survival rate relative to pupal survival. Note that ey-FLP-induced scrib /  RasV12 MARCM mosaics are 100% lethal (0% adult
survival) (P). Genotypes: (A,H,O) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/. FRT82B w+; (B) yw ey-FLP/+; act>y+>Gal4, UAS-
GFP56ST/+; FRT82B tub-Gal80/. FRT82B scrib2; (C) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-RasV12; FRT82B tub-Gal80/FRT82B w+; (D,E,P) yw ey-
FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (I–N,Q–U) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-X; FRT82B
tub-Gal80/UAS-RasV12 FRT82B scrib2 with UAS-X being UAS-lacZ (I), UAS-DuoxRNAi (J,Q), UAS-hCatS (K,R), UAS-Catalase (L,S), UAS-SOD1 (M,T) and
UAS-SOD2 (N,U).
DOI: https://doi.org/10.7554/eLife.26747.003
Figure 1 continued on next page
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by activating effector caspases such as mammalian Caspase-3 or its Drosophila ortholog DrICE
(Fuchs and Steller, 2011; Shalini et al., 2015; Salvesen et al., 2016). Caspases induce apoptosis of
many cells to maintain homeostatic conditions, and are also thought to be critical for tumor suppres-
sion by eliminating malignant cells.
However, caspases can also have tumor-promoting roles, for example through apoptosis-induced
proliferation (AiP), a caspase-driven process by which apoptotic cells produce mitogenic signals for
proliferation of neighboring surviving cells (Mollereau et al., 2013) (reviewed in [Fogarty and Berg-
mann, 2017; Ryoo and Bergmann, 2012]). There are two types of AiP. During ‘genuine’ AiP, apo-
ptotic cells release mitogenic factors before completing the apoptotic program. This type of AiP has
been described for regeneration and wound healing both in vertebrates and invertebrates
(Tseng et al., 2007; Fan and Bergmann, 2008; Chera et al., 2009; Li et al., 2010). ‘Genuine’ AiP
may also be involved in human pathologies such as cancer, and may account for increased cell prolif-
eration and repopulation of tumors following cytotoxic treatments (chemo- or radiotherapy) which
induces massive apoptosis (reviewed in [Fogarty and Bergmann, 2017; Ichim and Tait, 2016]). Cas-
pases play significant tumor-promoting roles in these settings (Li et al., 2010; Huang et al., 2011;
Donato et al., 2014; Cheng et al., 2015; Zhang et al., 2015; Kurtova et al., 2015).
The second type is ‘undead’ AiP. Here, the apoptosis pathway is induced upstream, but the exe-
cution of apoptosis is blocked. In Drosophila, apoptosis inhibition is achieved experimentally by
expression of the effector caspase inhibitor p35 which very specifically inhibits DrICE (Hay et al.,
1994; Meier et al., 2000; Hawkins et al., 2000). Therefore, because these cells have initiated the
apoptotic process and contain active Dronc, but cannot die, they are referred to as ‘undead’. In
‘undead’ cells, non-apoptotic functions of active Dronc can now be examined, one of which is the
release of mitogenic signals for induction of AiP which can lead to hyperplastic overgrowth
(Wells et al., 2006; Kondo et al., 2006; Huh et al., 2004; Ryoo et al., 2004; Martı´n et al., 2009;
Pe´rez-Garijo et al., 2009; Pe´rez-Garijo et al., 2004; Fan et al., 2014; Rudrapatna et al., 2013;
Pe´rez-Garijo et al., 2005). ‘Undead’ states of cells may also be present under pathological condi-
tions. For instance, it has been proposed that RasV12 can maintain apoptotic cells in an ‘undead’-like
state promoting tumorigenesis (Hirabayashi et al., 2013).
Mechanistically, we have shown that AiP-mediated hyperplastic overgrowth of ‘undead’ tissue
depends on a Dronc-initiated feedback amplification loop which involves reactive oxygen species
(ROS) – specifically extracellular ROS produced by the membrane-bound NADPH oxidase Duox –,
activation of macrophage-like hemocytes, secretion of Eiger by hemocytes, Eiger-dependent activa-
tion of JNK in epithelial disc and further activation of Dronc by JNK (Fogarty et al., 2016) (reviewed
by [Diwanji and Bergmann, 2017a; Diwanji and Bergmann, 2017b]). Therefore, similar to the
scrib /  RasV12 case, Eiger and JNK signaling have proliferation- and growth-promoting functions in
this ‘undead’ AiP model.
These similarities prompted us to investigate the role of ROS and caspases for tumor growth of
scrib /  RasV12 clones in Drosophila. We report that oncogenic Ras switches the pro-apoptotic activ-
ity of caspases into a tumor-promoting one and thereby maintains scrib /  RasV12 cells in an
‘undead’-like state. Consistently, inhibition of caspases blocks tumor growth and tissue invasion. The
tumor-promoting function of apoptotic caspases is dependent on the generation of intra- and extra-
cellular ROS which are required for neoplastic behavior of scrib /  RasV12 clones. Furthermore, cas-
pase-induced ROS are essential for the recruitment and activation of hemocytes at scrib /  RasV12
mosaic discs. Hemocytes signal back to tumorous epithelial cells to stimulate JNK signaling which
further promotes caspase activity. Thus, these events constitute a feedback amplification loop which
is necessary for neoplastic activity of scrib /  RasV12 cells. This work extends previous models about
the conversion of Eiger and JNK signaling from anti-tumor to pro-tumor roles by oncogenic Ras and
Figure 1 continued
The following figure supplements are available for figure 1:
Figure supplement 1. Caspase-dependent generation of ROS as revealed by H2DCF-DA labelings.
DOI: https://doi.org/10.7554/eLife.26747.004
Figure supplement 2. Strong induction of b-Gal by expression of UAS-lacZ in scrib /  RasV12 clones.
DOI: https://doi.org/10.7554/eLife.26747.005
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identifies caspases as essential components of this switch. In conclusion, although apoptotic cas-
pases are usually considered to be tumor suppressors, under certain conditions, for example in the
presence of oncogenic RasV12 in scrib mutant cells, they can also adopt a tumor-promoting role.
Results
ROS are required for neoplastic characteristics of scrib /  RasV12
mosaic discs
Recently, in a model of ‘undead’ AiP, we showed that Duox-generated ROS are important for activa-
tion of hemocytes, JNK signaling and hyperplastic overgrowth (Fogarty et al., 2016; Diwanji and
Bergmann, 2017a; Diwanji and Bergmann, 2017b). Therefore, we examined if ROS have a similar
function in the neoplastic scrib /  RasV12 tumor model in Drosophila. scrib /  RasV12 clones were
induced by MARCM using ey-FLP in eye/antennal imaginal discs, the traditional tissue for this model
(Brumby and Richardson, 2003; Pagliarini and Xu, 2003). The ROS indicator dihydroethidium
(DHE) strongly labels scrib /  RasV12 mutant clones in mosaic discs, while wild-type (wt), scrib / 
and RasV12-expressing clones are not labeled by DHE or very little (Figure 1A–D’; quantified in
Figure 1F; see also Figure 2A,A’). Similar results were reported recently (Katheder et al., 2017;
Manent et al., 2017). A different ROS indicator, H2DCF-DA, confirms these results (Figure 1—fig-
ure supplement 1A–C,G). scrib /  RasV12 clones display an increased diffuse cytosolic DHE labeling
(Figure 1E,E’). At the boundary of scrib /  RasV12 clones, several cells stain very intensely for DHE
(Figure 1E,E’; arrow head).
To examine the function of ROS in this neoplastic tumor model, we reduced their amount either
by down-regulating ROS-producing enzymes such as Duox or by overexpressing ROS-removing
enzymes such as catalases and superoxide dismutases (SOD). As shown previously, scrib /  RasV12
occupy a large portion of the eye/antennal imaginal disc and display a strong neoplastic tumor phe-
notype (Pagliarini and Xu, 2003) (see also Figure 2F). Because expression of the antioxidant
enzymes was achieved by the UAS/Gal4 system, we tested first whether increasing the UAS gene
dose may modify (suppress) the tumor phenotype and expressed an unrelated control gene, UAS-
lacZ, in scrib /  RasV12 clones. However, despite strong expression of b-Gal (Figure 1—figure sup-
plement 2), the tumor phenotype of scrib /  RasV12 eye/antennal imaginal discs is not significantly
suppressed by addition of an additional UAS-driven transgene (Figure 1I).
In contrast, removing extracellular ROS by UAS-Duox RNAi or overexpression of the UAS-hCatS
transgene which encodes a secreted human catalase (Ha et al., 2005b2005; Ha et al., 2005a),
strongly suppressed tumor growth of scrib /  RasV12 mutant cells (Figure 1J,K) suggesting that
extracellular ROS are required for tumor growth. Interestingly and in contrast to the ‘undead’ AiP
model, removing intracellular ROS by misexpression of intracellular Catalase, SOD1 and SOD2 also
strongly suppressed tumor growth (Figure 1L–N). These results suggest that both intra- and extra-
cellular ROS are required for tumor growth of scrib /  RasV12 clones.
Importantly also, reduction of ROS strongly reduces the invasive behavior of scrib /  RasV12
mutant cells (Figure 1J–N) which significantly improves the survival rate of the affected animals.
Compared to ey >MARCM scrib /  RasV12 mutant larvae, of which only 5% reach pupal stages,
between 40% and 70% of the ey >MARCM scrib /  RasV12 larvae expressing antioxidant enzymes
develop into pupae (Figure 1G). Expression of the UAS-lacZ control transgene does not improve
pupal survival (Figure 1G). Furthermore, we also recovered viable adult ey >MARCM scrib /  RasV12
mosaic animals expressing antioxidant genes, although at a low rate (5–15% of the surviving pupae),
which was never observed for scrib /  RasV12 only (Figure 1P–U). Although their eyes and heads are
deformed and weakly overgrown often with necrotic patches compared to wt control (Figure 1O,Q–
U), these animals live! Previously, only few examples of surviving scrib /  RasV12 mosaic animals have
been reported. In these examples, viable scrib /  RasV12 mosaic animals were recovered when
essential steps in tumor development such as oncogenic JNK signaling or the cell cycle were inhib-
ited in scrib /  RasV12 clones (Brumby and Richardson, 2003; Ku¨lshammer et al., 2015;
Ku¨lshammer and Uhlirova, 2013). Therefore, the observation that reduction of ROS suppresses
tumor growth and enhances organismal survival strongly suggests that ROS play a very significant
role for the neoplastic characteristics of scrib /  RasV12 animals.
Pe´rez et al. eLife 2017;6:e26747. DOI: https://doi.org/10.7554/eLife.26747 5 of 20
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Caspases promote tumors by inducing the generation of ROS
In ‘undead’ cells, the initiator caspase Dronc (caspase-9 ortholog) has been shown to stimulate the
production of ROS (Fogarty et al., 2016). Therefore, we examined the role of Dronc as well as the
effector caspase DrICE (caspase-3 ortholog) for generation of ROS and tumorous overgrowth in
scrib /  RasV12 mosaic eye discs. As an additional assay, we expressed the effector caspase inhibitor
Figure 2. Caspases are required for ROS generation and neoplastic overgrowth in scrib /  RasV12. (A–D’) Expression of the effector caspase inhibitor
p35 (B), drICE RNAi (C) and dronc RNAi (D) suppresses scrib /  RasV12 clone size (green) and ROS generation in scrib /  RasV12 clones. The (‘) panels
indicate the labeling of the ROS indicator DHE (grey). Scale bars: 50 mm. (E) DHE quantification reveals that ROS levels are significantly reduced in
scrib /  RasV12 mutant clones with reduced or inhibited caspase activity. Shown is the mean signal intensity ±SD of DHE labelings in clones, analyzed
by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p<0.0001. Multiple clones from five to ten discs of each genotype were
analyzed. (F–I) The growth and invasion of cephalic complexes of 11 day old scrib /  RasV12 larvae (F) is strongly suppressed by p35 (G), drICE RNAi (H)
and dronc RNAi (I). Clone size (green) in (F–I) is strongly reduced. DAPI labels the outline of the tissue. Scale bars: 200 mm. (J–M) Adult eyes of surviving
scrib /  RasV12 animals expressing p35 (K), drICE RNAi (L) and dronc RNAi (M). The percentage number in the top right of each panel indicates the
adult survival rate relative to pupal survival. (N) Reduction or inhibition of caspase activity in scrib /  RasV12 mutant clones significantly improves the
pupariation rates of animals bearing scrib /  RasV12 mosaic eye imaginal discs. Pupariation rates were determined as the ratio of late stage mutant
pupae vs total pupae and were analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are relative to
scrib /  RasV12 results (left column) and are indicated above the experimental columns. ****p<0.0001. At least 100 pupae were counted per genotype.
Experiments were performed three times. Genotypes: (A,F,J) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2;
(B–D,G–I,K–M) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-X; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2 with UAS-X being UAS-p35 (B,G,K), UAS-
drICERNAi (C,H,L) and UAS-droncRNAi (D,I,M).
DOI: https://doi.org/10.7554/eLife.26747.006
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p35 in scrib /  RasV12 mutant clones. Removing or inhibiting caspases in scrib /  RasV12 mutant
clones strongly reduced DHE labeling suggesting suppression of ROS generation (Figure 2A–D’;
quantified in Figure 2E). Similar results were obtained with a different ROS indicator, H2DCF-DA
(Figure 1—figure supplement 1C–G). Consequently, tumor overgrowth and invasion of the VNC is
dramatically reduced upon removal or inhibition of caspases in scrib /  RasV12 mutant cells
(Figure 2F–I). Reduction of caspase activity also increases pupal survival (Figure 2N) and viable ani-
mals with mosaic scrib /  RasV12 heads and eyes were recovered as adults at a rate of 4–9% of the
surviving pupae (Figure 2J–M).
The requirement of caspases for generation of ROS and neoplastic behavior suggests that cas-
pases are activated in scrib /  RasV12 mutant cells. To verify this, we labeled scrib /  RasV12 mosaic
eye discs with cleaved caspase-3 (CC3) antibody which detects activated (cleaved) effector caspases
and an unknown non-apoptotic substrate of Dronc (Fan and Bergmann, 2010; Srinivasan et al.,
1998). Indeed, while there is very little CC3 labeling in mosaic control discs (FRT +), scrib /  RasV12
mutant clones label significantly stronger with CC3 antibody (Figure 3A–B’, yellow arrowhead; quan-
tified in Figure 3D). In addition to the CC3 labeling in scrib /  RasV12 clones, there is also staining
immediately outside the clones which appears even more intense than the labeling inside the clones
(Figure 3B,B’; white arrows). In fact, quantification reveals that this non-autonomous CC3 labeling is
2 to 2.5-fold higher than autonomous CC3 labeling in scrib /  RasV12 clones (Figure 3D). Both, CC3
labeling inside and outside of scrib /  RasV12 clones are autonomously dependent on the caspases
DrICE (Figure 3C) and Dronc as well as on ROS (Figure 3—figure supplement 1).
Labeling with the CC3 antibody indicates active Dronc both in apoptotic and non-apoptotic cells
(Fan and Bergmann, 2010; Fan et al., 2014). Therefore, because of the strong tumor growth of
scrib /  RasV12 mosaics, we wondered if the CC3-positive cells in scrib /  RasV12 clones are actually
apoptotic and labeled scrib /  RasV12 discs with TUNEL, an apoptotic assay that detects DNA frag-
mentation, a hallmark of apoptosis downstream of effector caspases (Gavrieli et al., 1992). Interest-
ingly, although a few TUNEL-positive cells are detectable within scrib /  RasV12 clones, the majority
of TUNEL-positive cells are located outside the clones (Figure 3E,E’; arrows). Quantification reveals
that almost 90% of all apoptotic cells in scrib /  RasV12 mosaic discs are outside the mutant clones
(Figure 3F).
These observations allow us to make an important conclusion. Despite detectable caspase
(Dronc) activity in scrib /  RasV12 mutant clones by CC3 labeling, this activity does not appear to
trigger a significant amount of apoptosis in these clones. In contrast, our genetic analysis suggest
that the strong tumor growth phenotype of scrib /  RasV12 mosaic eye discs is dependent on cas-
pases (Figure 2) suggesting that they have adopted a tumor-promoting function. This is surprising
as caspase activity and apoptosis in general are thought to act as tumor suppressors (Hanahan and
Weinberg, 2011; Hanahan and Weinberg, 2000). In fact, caspase activity in scrib /  single mutant
cells does act as a tumor suppressor by killing them (Brumby and Richardson, 2003; Igaki et al.,
2006; Igaki et al., 2009; Uhlirova et al., 2005; Chen et al., 2012). In contrast, in scrib /  RasV12
mutant cells, this caspase activity persists, but does not appear to induce a significant amount of
apoptosis. Therefore, these data suggest that RasV12 maintains scrib /  cells in an ‘undead’-like con-
dition, consistent with a previous report (Hirabayashi et al., 2013). Furthermore, RasV12 changes the
activity of caspases to adopt a tumor-promoting role.
Hemocyte recruitment to scrib /  RasV12 tumors depends on caspase-
generated ROS
Next, we examined the role of ROS for neoplastic growth of scrib /  RasV12 mosaic discs. One
known function of extracellular ROS is the recruitment and activation of Drosophila macrophages
(hemocytes) in the ‘undead’ AiP model (Diwanji and Bergmann, 2017a; Fogarty et al., 2016;
Diwanji and Bergmann, 2017b). Hemocytes have been shown to be associated with scrib /  RasV12
mosaic discs (Cordero et al., 2010; Pastor-Pareja et al., 2008; Ku¨lshammer and Uhlirova, 2013).
Therefore, we tested if ROS contribute to the recruitment and activation of hemocytes to scrib / 
RasV12 mosaic eye imaginal discs. At control discs, hemocytes adhere in small cellular aggregates,
mostly at the antennal disc (Figure 4A,A’,L). In contrast, they are recruited to neoplastic scrib / 
RasV12 tumor sites in large numbers where they cover the eye portion of the disc (Figure 4B,B’;
quantified in Figure 4K) consistent with previous reports (Cordero et al., 2010; Pastor-
Pareja et al., 2008; Ku¨lshammer and Uhlirova, 2013). They also change their morphological
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appearance at neoplastic scrib /  RasV12 discs. They single out from the cellular clusters and develop
cellular protrusions, similar to cytonemes (Figure 4M, arrows). This change in cellular behavior and
morphology of hemocytes was also observed in the ‘undead’ AiP model (Fogarty et al., 2016).
Figure 3. Analysis of caspase activity and apoptosis in scrib /  RasV12 mosaic eye discs. (A–C’) Cleaved caspase 3
(CC3) (red in (A–C); grey in (A’–C’)) analysis of control (wt, FRT +) (A), scrib /  RasV12 (B) and scrib /  RasV12
expressing drICE RNAi (C) mosaic eye imaginal discs. CC3 labeling is detectable autonomously (yellow arrowhead)
and non-autonomously (white arrows) of scrib /  RasV12 mutant clones (B’). Clones in (B’) and (C’) are outlined by
yellow, dotted lines. Scale bars: 50 mm. (D) CC3 quantification of mosaic FRT + (control), scrib /  RasV12 and
drICERNAi;scrib /  RasV12 eye-antennal imaginal discs reveals significant increase of caspase activity both inside
(autonomously) and outside (non-autonomously) of scrib /  RasV12 clones. Plotted is the mean signal intensity ±SD
of autonomous and non-autonomous CC3 labelings, immediately adjacent to the clones. Analysis was performed
by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p<0.0001; **p<0.01; ns – not significant.
Ten discs per genotype were analyzed. (E) TUNEL assay as an apoptotic marker of scrib /  RasV12 mosaic eye
discs. White arrows mark TUNEL-positive cells outside scrib /  RasV12 clones, outlined by yellow dotted lines. (F)
TUNEL quantification reveals that almost 90% of apoptotic cells in scrib /  RasV12 mosaic discs are outside of
mutant clones. Autonomous and non-autonomous counts of TUNEL-positive cells were analyzed by paired
student’s t-test. ****p<0.0001. The distribution of TUNEL-positive cells in seven discs is plotted. Genotypes: (A) yw
ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/. FRT82B w+; (B,E) yw ey-FLP/+; act>y+>Gal4, UAS-
GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (C) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-
drICERNAi; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2.
DOI: https://doi.org/10.7554/eLife.26747.007
The following figure supplement is available for figure 3:
Figure supplement 1. Reduction of ROS results in loss of caspase activity in scrib /  RasV12 mosaic discs.
DOI: https://doi.org/10.7554/eLife.26747.008
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We examined if ROS and caspases are required for hemocyte recruitment to scrib /  RasV12
mosaic discs. Indeed, reduction of ROS strongly reduces the recruitment of hemocytes to scrib / 
RasV12 mosaic discs (Figure 4C–F’). Likewise, the recruitment of hemocytes to scrib /  RasV12 tumors
is impaired by loss of caspase activity (Figure 4G–I’). Quantification of hemocyte recruitment to
ROS-depleted or caspase-inhibited scrib /  RasV12 discs normalized to GFP (to account for the
Figure 4. Caspase-generated ROS are required of recruitment and activation of hemocytes to scrib /  RasV12 mosaic eye/antennal imaginal discs.
Hemocytes were labeled with the NimC antibody (Kurucz et al., 2007) (red in top panels; grey in (‘) panels and in (L–R)). Scale bars in (A–J’): 50 mm; in
(L–R): 100 mm. (A,A’) Control mosaic discs (FRT +) carry small hemocyte clusters mostly at the antennal portion of the disc. (B,B’) scrib /  RasV12 mosaic
discs are covered by large quantities of hemocytes. + indicates scrib /  RasV12 in otherwise wt background. (C–I) Hemocyte recruitment to scrib / 
RasV12 eye/antennal imaginal discs is strongly impaired upon loss of ROS (C–F’) and caspase activity (G–I’). (J,J’) Expression of a dominant negative JNK
transgene (JNKDN) in scrib /  RasV12 mutant clones blocks hemocyte recruitment. (K) Quantification of NimC labelings reveals that the number of
hemocytes attached to scrib /  RasV12 mosaic discs is significantly lower when ROS levels or caspase activity are reduced in scrib /  RasV12 clones. To
facilitate the quantification, the mean intensity of NimC labelings across the entire disc was determined, normalized to GFP (to account for the reduced
size of ROS-depleted or caspase-inhibited scrib /  RasV12 clones) and analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons.
Error bars are SD. P values are referenced to scrib /  RasV12 and are indicated by asterisks above each column. ****p<0.0001. Ten discs per genotype
were analyzed. + indicates scrib /  RasV12 in otherwise wt background. (L–R) High magnification images of hemocytes attached to the discs of
indicated genotype. Note that in (M) hemocytes attached to scrib /  RasV12 discs extend cellular protrusions (arrows), similar to cytonemes. These
protrusions are absent in hemocytes attached to control (L) and caspase-inhibited or ROS-depleted discs (N–R). + in (M) indicates scrib /  RasV12 in
otherwise wt background. Genotypes: (A,L) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/. FRT82B w+; (B,M) yw ey-FLP/+;
act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (C–I, N–R) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/UAS-X; FRT82B tub-
Gal80/UAS-RasV12 FRT82B scrib2 with UAS-X being UAS-DuoxRNAi (C), UAS-hCatS (D,N), UAS-SOD1 (E), UAS-Catalase (F,O), UAS-SOD2 (P), UAS-
droncRNAi (G,Q), UAS-drICERNAi (H,R) and UAS-p35 (I). (J) yw ey-FLP/UAS-JNKDN; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B
scrib2.
DOI: https://doi.org/10.7554/eLife.26747.009
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reduced size of ROS-depleted or caspase-inhibited scrib /  RasV12 clones), revealed a significant
loss of hemocytes compared to scrib /  RasV12 mosaic discs (Figure 4K). For example, more than
90% of scrib /  RasV12 discs expressing Duox RNAi are not attached by any hemocyte despite the
presence of many small clones (Figure 4C’). Furthermore, in addition to the significant loss of hemo-
cytes, the few hemocytes that are attached to ROS- and caspase-depleted scrib RasV12 discs
(Figure 4D’–I’), display the naive morphology seen at control discs (Figure 4N–R). These observa-
tions provide strong evidence that caspase-dependent generation of ROS is essential for recruitment
and activation of hemocytes to scrib /  RasV12 tumors.
Caspase activation and ROS generation depends on JNK signaling
As reported previously, JNK activity is strongly induced in scrib /  RasV12 clones (Figure 5C) and is
essential for the neoplastic phenotype of scrib /  RasV12 mosaic animals (Brumby and Richardson,
2003; Igaki et al., 2006; Igaki et al., 2009; Uhlirova et al., 2005; Leong et al., 2009;
Cordero et al., 2010). In fact, activation of JNK in oncogenic RasV12 background is sufficient to trig-
ger a neoplastic tumor phenotype similar to the scrib /  RasV12 condition (Uhlirova et al., 2005;
Uhlirova and Bohmann, 2006). Therefore, we examined the relation between ROS, caspases and
JNK signaling. In a first set of experiments, we blocked JNK signaling by expressing a dominant neg-
ative JNK construct (JNKDN) in scrib /  RasV12 mutant clones. In JNKDN-expressing scrib /  RasV12
mutant clones, caspase activity (CC3) and ROS production are strongly reduced (Figure 5A–B’).
Likewise, the recruitment and activation of hemocytes is strongly impaired at JNKDN; scrib /  RasV12
discs (Figure 4J) consistent with a previous report (Ku¨lshammer and Uhlirova, 2013). These find-
ings suggest that caspase activation, ROS generation and hemocyte activation are dependent on
JNK signaling.
In the second set of experiments, we examined if there is a dependence of JNK signaling on cas-
pases and ROS using anti-phosphoJNK (pJNK) antibody as a JNK activity marker. These labelings
revealed a significant loss of JNK activity in caspase-inhibited or ROS-depleted scrib /  RasV12
clones (Figure 5D–K’; quantified in Figure 5L). Similar results were obtained using MMP1 antibody
labeling as an additional JNK marker (Figure 5—figure supplement 1). These observations suggest
that the maintenance of JNK activity requires caspases and ROS. Combined, these results imply that
JNK is acting both upstream (Figure 5A,B) and downstream (Figure 5E–L) of caspases and ROS.
The easiest way to explain such a behavior is that caspases, ROS, hemocytes and JNK signaling con-
stitute an amplification loop in scrib /  RasV12 mutant clones similar to the ‘undead’ AiP model
(Diwanji and Bergmann, 2017a; Fogarty et al., 2016).
Discussion
The traditional view of caspases holds that they counter tumorigenesis by eliminating tumor cells
and thus mediate a tumor suppressor function (Hanahan and Weinberg, 2000; Hanahan and Wein-
berg, 2011). This tumor-suppressing function of caspases has been reported in mammalian systems
(Asselin-Labat et al., 2011; Ho et al., 2009) and in Drosophila, where, for example, scrib mutant
cells undergo caspase-dependent apoptosis in a JNK- and Eiger-dependent manner (Brumby and
Richardson, 2003; Igaki et al., 2006; Igaki et al., 2009; Uhlirova et al., 2005). However, more
recent work has suggested that caspases and apoptosis in general can also have the opposite,
tumor-promoting function, both in flies and in mammals (Cheng et al., 2015; Donato et al., 2014;
Huang et al., 2011; Kurtova et al., 2015; Li et al., 2010; Zhang et al., 2015); reviewed by
(Ryoo and Bergmann, 2012; Ichim and Tait, 2016; Fogarty and Bergmann, 2017). Furthermore, in
Drosophila it was previously shown that oncogenic Ras switches the tumor-suppressing function of
JNK and Eiger in scrib /  mutant cells to a tumor-promoting one in scrib /  RasV12 cells
(Igaki et al., 2006; Cordero et al., 2010; Uhlirova et al., 2005; Enomoto et al., 2015). Mechanistic
details about this oncogenic switch have been largely elusive. Our data presented here imply that a
critical step for this oncogenic switch is the conversion of caspase activity by oncogenic Ras.
Consistent with a previous report in different context (Hirabayashi et al., 2013), our results dem-
onstrated that oncogenic Ras can suppress the apoptotic activity of caspases and keeps scrib / 
RasV12 cells in an ‘undead’-like condition. While caspases may still induce apoptosis in a few tumor
cells, they now largely promote generation of intra- and extracellular ROS which are required for
malignant growth and tissue invasion of surviving neoplastic cells. Evidence that caspases are indeed
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Figure 5. JNK acts upstream and downstream of caspase activation and ROS generation. (A–B’) Expression of JNKDN in scrib /  RasV12 clones inhibits
caspase activity (A,A’; CC3) and ROS generation (B,B’; DHE). Scale bars: 50 mm. (C–K’) pJNK labeling (red in (C–K); grey in (C’–K’)) as JNK marker in
scrib /  RasV12 (C,C’), JNKDN-expressing scrib /  RasV12 (D,D’) and ROS-depleted or caspase-inhibited scrib /  RasV12 mosaic discs (E–K’). The strong
pJNK labeling in (C,C’) is significantly reduced in (D–K’). Scale bars: 50 mm. (L) The mean intensity of pJNK labelings in scrib /  RasV12 clones in panels
Figure 5 continued on next page
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activated in scrib /  RasV12 clones is not only provided in this study, but also in a report that showed
that small malignant clones (lgl /  RasV12) undergo caspase-mediated apoptosis and elimination in a
similar way as scrib clones (Mene´ndez et al., 2010). Only when mutant clones have reached a cer-
tain size, can they develop malignant tumors despite intrinsic caspase activation (Mene´ndez et al.,
2010; Ballesteros-Arias et al., 2014).
Our data suggest that JNK activity acts both upstream and downstream of caspases and ROS
generation in scrib /  RasV12 mutant clones (Figure 5). It is possible that initially, when the scrib / 
RasV12 mutant cells form, a cell competition signal triggers JNK activation in scrib /  RasV12 cells,
similar to the events in scrib / -only mutant cells (Figure 6). In both scrib /  and scrib /  RasV12
mutant cells, this JNK activity results in caspase activation (Figures 3 and 5A). However, due to the
anti-apoptotic activity of RasV12, caspases induce only very little apoptosis in scrib RasV12 clones (Fig-
ure 3). Therefore, although caspases are active, most scrib /  RasV12 cells do not die and thus are in
an ‘undead’-like state. Caspases now promote the generation of extracellular ROS through activa-
tion of NADPH oxidase Duox. These ROS recruit and activate hemocytes (Figure 4). It is known that
hemocytes can release Eiger (Cordero et al., 2010; Parisi et al., 2014; Fogarty et al., 2016) which
signals through its receptor Grindelwald (Andersen et al., 2015) for further stimulation of JNK activ-
ity in scrib /  RasV12 cells. Thus, we postulate that JNK, caspases, ROS, hemocytes and Eiger consti-
tute an amplification loop (Figure 6) which may be necessary for tumor initiation.
Evidence of an amplification loop is provided by the mutual dependence of caspases, ROS and
JNK (Figure 5; Figure 3—figure supplement 1). Similar amplification loops have been described in
apoptotic and ‘undead’ cells (Wells et al., 2006; Shlevkov and Morata, 2012; Fogarty et al.,
2016). This amplification loop ensures persistent oncogenic signaling in scrib /  RasV12 cells. This is
in striking contrast to scrib /  mutant cells alone in which JNK signaling triggers linear caspase acti-
vation and apoptosis (Brumby and Richardson, 2003; Igaki et al., 2006; Igaki et al., 2009;
Uhlirova et al., 2005). In later stages of tumorigenesis, the amplification loop may have reached full
strength and promotes malignant growth and invasion of scrib /  RasV12 cells (Figure 6). Amplifica-
tion loops have also been observed in other neoplastic tumor models in Drosophila. For example,
intestinal stem cell tumors form in response to an amplification loop (Chen et al., 2016). In a glyco-
lytic tumor model, ROS are also part of a amplification loop that facilitates metabolic reprogram-
ming (Wang et al., 2016). Thus, it is possible that tumorigenesis in general depends on
amplification loops to sustain oncogenic signaling.
There are similarities and differences in the amplification loops of the ‘undead’ hyperplastic AiP
model and the neoplastic scrib /  RasV12 tumor model. In both models, caspases, ROS, hemocytes
and JNK are required for growth. However, regarding caspases, the ‘undead’ AiP model only
involves the initiator caspase Dronc for growth (in fact, effector caspases are inhibited by P35 in this
model) (Fan et al., 2014; Huh et al., 2004; Pe´rez-Garijo et al., 2004; Pe´rez-Garijo et al., 2009;
Ryoo et al., 2004). In contrast, the neoplastic scrib /  RasV12 model requires both initiator (Dronc)
and effector (DrICE) caspases. Inhibition of either suppresses malignant growth and invasion.
Another interesting difference is the differential involvement of ROS. While only extracellular ROS
are essential in the ‘undead’ AiP model, neoplastic growth of scrib /  RasV12 cells requires both
intra- and extracellular ROS. Mitochondria are the likely source of intracellular ROS because expres-
sion of mitochondrial SOD2 can suppress tumor growth and invasion of scrib /  RasV12 tumors
(Figure 1N). It is unclear if these two populations of ROS are dependent or independent of each
Figure 5 continued
(C’–K’) is significantly reduced upon ROS-depletion or reduction of caspase activity. Analysis of JNK labelings was done by one-way ANOVA with Holm-
Sidak test for multiple comparisons. Error bars are SD. P values are referenced to scrib /  RasV12 and are indicated by asterisks above each column.
****p<0.0001. At least ten discs per genotype were analyzed. Genotypes: (A,B,D) yw ey-FLP/UAS-JNKDN; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-
Gal80/UAS-RasV12 FRT82B scrib2; (C) yw ey-FLP/+; act>y+>Gal4, UAS-GFP56ST/+; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2; (E–K) yw ey-FLP/+;
act>y+>Gal4, UAS-GFP56ST/UAS-X; FRT82B tub-Gal80/UAS-RasV12 FRT82B scrib2 with UAS-X being UAS-droncRNAi (E), UAS-drICERNAi (F), UAS-p35 (G),
UAS-DuoxRNAi (H), UAS-hCatS (I), UAS-Catalase (J) and UAS-SOD2 (K).
DOI: https://doi.org/10.7554/eLife.26747.010
The following figure supplement is available for figure 5:
Figure supplement 1. MMP1 labeling is reduced in scrib /  RasV12 clones with reduced ROS or caspase activity.
DOI: https://doi.org/10.7554/eLife.26747.011
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other. Recently, it was shown in endothelial cells that Nox-derived ROS can trigger an increase in
mitochondrially-derived ROS and loss of mitochondrial membrane potential suggesting a depen-
dence of mitochondrial ROS from Nox-generated ROS (Shafique et al., 2017). However, alterna-
tively, it is also possible that intra- and extracellular ROS are produced independently by caspase
activity, and both are separately required for neoplastic transformation.
Furthermore, while we mostly focused from the point-of-view of ‘undead’ AiP, it is also possible
that ‘genuine’ AiP contributes to the tumor growth in scrib /  RasV12. Consistent with this notion is
the observation that there are a few apoptotic cells in scrib /  RasV12 mutant clones (Figure 3E’,F).
Genuinely apoptotic cells can also produce ROS in Drosophila imaginal discs (Santaba´rbara-
Ruiz et al., 2015). Therefore, it is tempting to speculate that some of the differences between the



































Figure 6. Mechanistic view about the conversion of caspases from tumor suppressors to tumors promoters in scrib RasV12 mutant cells. (A) After
scrib /  mutant cells have formed in mosaic discs, a cell competition signal mediated by Eiger triggers JNK and caspase activity which induces
apoptosis of scrib mutant cells (dashed outline of the cell). (B) After scrib /  RasV12 cells have formed, JNK activity may be induced by the same cell
competition signal as in scrib /  mutant cells (early). However, despite activation of JNK and caspases in scrib RasV12 cells, RasV12 keeps these cells in
an ‘undead’-like condition and enables caspases to initiate a feedback amplification loop involving ROS generation and recruitment of hemocytes
which amplifies JNK and caspase activity (late). This amplification loop is necessary for malignant growth and invasion. Neighboring wild-type cells
undergo apoptosis (dashed outline of the cell). The mechanism of non-autonomous apoptosis is not clear.
DOI: https://doi.org/10.7554/eLife.26747.012
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‘genuine’ AiP in scrib /  RasV12. This may explain the differences in caspase requirement, the differ-
ences in ROS production and the different outcomes of growth – hyperplastic vs. neoplastic –
between the ‘undead’ AiP and the scrib /  RasV12 tumor models. Future work will address this
important question.
Another important question for future studies will be to address how RasV12 switches the activity
of caspases from tumor-suppressors to tumor-promoters. A known target of survival signaling by
RasV12 is the pro-apoptotic gene Hid which acts upstream of caspase activation (Bergmann et al.,
1998; Kurada and White, 1998). Because Eiger and JNK can induce expression of hid
(Moreno et al., 2002), it is possible that Hid activity is inhibited by oncogenic Ras. However, while
we do not exclude this possibility, it alone may not be sufficient to explain the altered caspase activ-
ity because inhibition of hid would result in loss of caspase activity. However, caspases are still active
in scrib /  RasV12 mutant cells (Figure 3B,D) and they are also able to induce apoptosis at least in a
small amount of mutant cells (Figure 3E,F). Therefore, it is possible that RasV12 modifies caspase
activity in a different manner – directly or indirectly – for non-apoptotic ROS generation.
Oncogenic Ras is mediating many steps in the tumorigenic process of scrib /  RasV12 tissue. It
changes the transcriptome of these cells and modifies the downstream activities of JNK
(Atkins et al., 2016; Ku¨lshammer et al., 2015). However, as shown in this work, a critical step medi-
ated by RasV12 is the modification of caspase activity – directly or indirectly – in the early stage of
tumorigenesis in a way that the cells survive. At present it is unclear if the caspase-modulating activ-
ity of RasV12 is dependent on transcription. There may not be enough time for a transcriptional
response by the cell to escape the apoptotic activity of caspases. Consistently, work by others has
suggested that changes in the transcriptome alone does not fully explain the neoplastic phenotype
of scrib /  RasV12 cells and that other potentially non-transcriptional processes are involved
(Atkins et al., 2016). Modification of caspase activity may be one of these non-transcriptional
processes.
Non-apoptotic functions of caspases have been reported (Shalini et al., 2015; Fogarty and Berg-
mann, 2017; Mukherjee and Williams, 2017; Nakajima and Kuranaga, 2017). However, it is largely
unknown how cells survive in the presence of activated caspases during non-apoptotic processes. It
is possible that a reduction of caspase activity below a certain apoptotic threshold is sufficient for
survival. Other models include changes in the subcellular localization of caspases or interaction with
modifying factors such as Tango7 (D’Brot et al., 2013). Interesting in this respect is a recent study
which showed that mitochondrially-derived SCSb restricts caspase activity for spermatid maturation
in the Drosophila testis (Aram et al., 2016). Since mitochondria release apoptotic signaling mole-
cules such as cytochrome c and Smac during apoptosis (Fuchs and Steller, 2011), it may also be
possible that they release signals such as SCSb or related factors which modulate the activity of cas-
pases for non-apoptotic functions. More work is necessary to address these essential questions for
understanding of tumor initiation and progression.
Materials and methods
Drosophila genetics
The scrib allele used is scrib2 (also known as scrib673) (Bilder and Perrimon, 2000). The recombinant
UAS-RasV12 FRT82B scrib2 (Chen et al., 2012; Pe´rez et al., 2015) line was a kind gift of Madhuri
Kango-Singh (U Dayton, OH, USA). The MARCM system (Lee and Luo, 1999) with ey-FLP
(Newsome et al., 2000) was used to generate mosaics of eye/antennal imaginal discs and experi-
mental clones were marked by GFP. In (Figure 1—figure supplement 1), we used a modified
MARCM system that marks clones with myrRFP (Chabu and Xu, 2014). The wt control line (FRT +) is
FRT82B (Xu and Rubin, 1993).
The following transgenes are all inserted on chromosome 2 and were crossed into the scrib / 
RasV12 background for analysis: UAS-lacZ (Bloomington, BL3955), UAS-Duox RNAi and UAS-hCatS (a
kind gift of Won-Jae Lee) (Ha et al., 2005a; Ha et al., 2005b2005), UAS-Catalase (BL24621), UAS-
SOD1 (BL24754), UAS-SOD2 (BL24494), UAS-p35 (BL5072), UAS-dronc RNAi and UAS-drICE RNAi
(a kind gift of Pascal Meier) (Leulier et al., 2006). UAS-JNKDN (aka UAS-bskDN) (BL6409) is an inser-
tion on X chromosome. Crosses were incubated at either 22˚ or 25˚C.
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Imaging and quantification
DHE and H2DCF-DA (both from Invitrogen/Molecular Probes) labeling of unfixed tissue was per-
formed as described (Owusu-Ansah et al., 2008). TUNEL labeling (Roche) was done according to
the manufacturer’s instructions. Antibody labelings were done on fixed tissue following standard
procedures (Fan and Bergmann, 2014; Fogarty and Bergmann, 2014). The following antibodies
were used: cleaved caspase-3 (CC3; Cell Signaling Technology); NimC (kind gift of I. Ando´)
(Kurucz et al., 2007); MMP1 (Developmental Studies Hybridoma Bank (DSHB)) and pJNK (Prom-
ega). Secondary antibodies were donkey Fab fragments from Jackson Immunoresearch. Eye/anten-
nal cephalic complexes were counterlabeled with the nuclear dye DAPI to visualize tissue outline.
Images were taken with a Zeiss LSM700 confocal microscope. For quantification of confocal images,
the ‘Record Measurement’ function of Photoshop was used. Clones were outlined and signal inten-
sity determined. Multiple clones of five to ten imaginal discs per genotype obtained in three inde-
pendent experiments were measured. Analysis and graph generation was done using GraphPad
Prism 7.03. The statistical method and the P values are indicated in the figure legends.
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